US Stock MarketDetailed Quotes

TLIS Talis Biomedical

Watchlist
  • 1.750
  • -0.150-7.89%
15min DelayTrading Sep 11 10:39 ET
3.19MMarket Cap-62P/E (TTM)

Talis Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.62%-11.33M
60.97%-6.43M
46.83%-53.24M
16.14%-11.36M
46.48%-11.14M
35.16%-14.27M
62.37%-16.47M
41.57%-100.14M
66.76%-13.54M
72.14%-20.82M
Net income from continuing operations
41.14%-8.85M
26.90%-13.04M
45.13%-62.01M
50.02%-13.46M
39.73%-15.68M
44.34%-15.03M
46.05%-17.83M
41.15%-113.01M
6.02%-26.93M
32.27%-26.02M
Depreciation and amortization
-50.00%84K
50.57%262K
-91.28%770K
-94.08%211K
-94.47%217K
-82.86%168K
-52.07%174K
459.57%8.83M
280.15%3.56M
1,599.13%3.93M
Other non cash items
-90.77%247K
-48.66%403K
55.32%4.3M
-50.73%403K
-53.33%441K
346.58%2.68M
91.93%785K
165.68%2.77M
2,626.67%818K
94.85%945K
Change In working capital
-46.82%-4.64M
147.81%371K
55.45%-3.42M
-88.65%469K
104.34%42K
-245.31%-3.16M
94.04%-776K
-187.10%-7.69M
125.47%4.13M
97.55%-967K
-Change in receivables
101.72%7K
-76.37%43K
307.20%259K
-136.00%-45K
160.10%528K
-120.67%-406K
107.53%182K
-143.40%-125K
247.22%125K
299.02%203K
-Change in inventory
----
----
----
----
----
----
----
----
----
--192K
-Change in prepaid assets
-297.81%-2.91M
-94.11%76K
211.09%1.88M
-53.52%628K
-56.89%691K
-152.29%-731K
134.45%1.29M
-94.85%604K
288.22%1.35M
-15.85%1.6M
-Change in payables and accrued expense
14.09%-1.74M
111.20%252K
37.55%-5.56M
-447.45%-2.18M
130.09%891K
10.17%-2.02M
47.96%-2.25M
-468.32%-8.91M
105.05%628K
92.82%-2.96M
-Change in other current assets
----
----
--0
--0
----
----
----
--741K
---239K
--0
-Change in other current liabilities
----
----
----
----
----
----
----
----
----
96.40%-4K
Cash from discontinued investing activities
Operating cash flow
20.62%-11.33M
60.97%-6.43M
46.83%-53.24M
16.14%-11.36M
46.48%-11.14M
35.16%-14.27M
62.37%-16.47M
41.57%-100.14M
66.76%-13.54M
72.14%-20.82M
Investing cash flow
Cash flow from continuing investing activities
117.32%84K
225.00%30K
69.91%-486K
289.80%93K
91.86%-70K
-143.72%-485K
95.27%-24K
43.65%-1.62M
95.04%-49K
-13.31%-860K
Net PPE purchase and sale
117.32%84K
225.00%30K
69.91%-486K
289.80%93K
91.86%-70K
-143.72%-485K
95.27%-24K
43.65%-1.62M
95.04%-49K
-13.31%-860K
Cash from discontinued investing activities
Investing cash flow
117.32%84K
225.00%30K
69.91%-486K
289.80%93K
91.86%-70K
-143.72%-485K
95.27%-24K
43.65%-1.62M
95.04%-49K
-13.31%-860K
Financing cash flow
Cash flow from continuing financing activities
0
-93.94%2K
-91.87%33K
0
0
0
-89.49%33K
-99.83%406K
0
-90.82%92K
Proceeds from stock option exercised by employees
--0
-93.94%2K
-91.87%33K
--0
--0
--0
-89.49%33K
-78.44%406K
--0
-90.82%92K
Cash from discontinued financing activities
Financing cash flow
--0
-93.94%2K
-91.87%33K
--0
--0
--0
-89.49%33K
-99.83%406K
--0
-90.82%92K
Net cash flow
Beginning cash position
-37.77%71.88M
-40.69%78.27M
-43.44%131.97M
-38.49%89.54M
-39.72%100.75M
-39.00%115.51M
-43.44%131.97M
34.76%233.31M
-46.95%145.56M
-52.09%167.15M
Current changes in cash
23.80%-11.25M
61.14%-6.4M
47.02%-53.69M
17.13%-11.26M
48.06%-11.21M
33.55%-14.76M
62.56%-16.46M
-268.41%-101.35M
66.90%-13.59M
71.02%-21.59M
End cash Position
-39.82%60.63M
-37.77%71.88M
-40.69%78.27M
-40.69%78.27M
-38.49%89.54M
-39.72%100.75M
-39.00%115.51M
-43.44%131.97M
-43.44%131.97M
-46.95%145.56M
Free cash flow
23.23%-11.33M
61.02%-6.43M
47.20%-53.73M
17.13%-11.26M
48.28%-11.21M
33.55%-14.76M
62.75%-16.49M
41.61%-101.75M
67.43%-13.59M
71.28%-21.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.62%-11.33M60.97%-6.43M46.83%-53.24M16.14%-11.36M46.48%-11.14M35.16%-14.27M62.37%-16.47M41.57%-100.14M66.76%-13.54M72.14%-20.82M
Net income from continuing operations 41.14%-8.85M26.90%-13.04M45.13%-62.01M50.02%-13.46M39.73%-15.68M44.34%-15.03M46.05%-17.83M41.15%-113.01M6.02%-26.93M32.27%-26.02M
Depreciation and amortization -50.00%84K50.57%262K-91.28%770K-94.08%211K-94.47%217K-82.86%168K-52.07%174K459.57%8.83M280.15%3.56M1,599.13%3.93M
Other non cash items -90.77%247K-48.66%403K55.32%4.3M-50.73%403K-53.33%441K346.58%2.68M91.93%785K165.68%2.77M2,626.67%818K94.85%945K
Change In working capital -46.82%-4.64M147.81%371K55.45%-3.42M-88.65%469K104.34%42K-245.31%-3.16M94.04%-776K-187.10%-7.69M125.47%4.13M97.55%-967K
-Change in receivables 101.72%7K-76.37%43K307.20%259K-136.00%-45K160.10%528K-120.67%-406K107.53%182K-143.40%-125K247.22%125K299.02%203K
-Change in inventory --------------------------------------192K
-Change in prepaid assets -297.81%-2.91M-94.11%76K211.09%1.88M-53.52%628K-56.89%691K-152.29%-731K134.45%1.29M-94.85%604K288.22%1.35M-15.85%1.6M
-Change in payables and accrued expense 14.09%-1.74M111.20%252K37.55%-5.56M-447.45%-2.18M130.09%891K10.17%-2.02M47.96%-2.25M-468.32%-8.91M105.05%628K92.82%-2.96M
-Change in other current assets ----------0--0--------------741K---239K--0
-Change in other current liabilities ------------------------------------96.40%-4K
Cash from discontinued investing activities
Operating cash flow 20.62%-11.33M60.97%-6.43M46.83%-53.24M16.14%-11.36M46.48%-11.14M35.16%-14.27M62.37%-16.47M41.57%-100.14M66.76%-13.54M72.14%-20.82M
Investing cash flow
Cash flow from continuing investing activities 117.32%84K225.00%30K69.91%-486K289.80%93K91.86%-70K-143.72%-485K95.27%-24K43.65%-1.62M95.04%-49K-13.31%-860K
Net PPE purchase and sale 117.32%84K225.00%30K69.91%-486K289.80%93K91.86%-70K-143.72%-485K95.27%-24K43.65%-1.62M95.04%-49K-13.31%-860K
Cash from discontinued investing activities
Investing cash flow 117.32%84K225.00%30K69.91%-486K289.80%93K91.86%-70K-143.72%-485K95.27%-24K43.65%-1.62M95.04%-49K-13.31%-860K
Financing cash flow
Cash flow from continuing financing activities 0-93.94%2K-91.87%33K000-89.49%33K-99.83%406K0-90.82%92K
Proceeds from stock option exercised by employees --0-93.94%2K-91.87%33K--0--0--0-89.49%33K-78.44%406K--0-90.82%92K
Cash from discontinued financing activities
Financing cash flow --0-93.94%2K-91.87%33K--0--0--0-89.49%33K-99.83%406K--0-90.82%92K
Net cash flow
Beginning cash position -37.77%71.88M-40.69%78.27M-43.44%131.97M-38.49%89.54M-39.72%100.75M-39.00%115.51M-43.44%131.97M34.76%233.31M-46.95%145.56M-52.09%167.15M
Current changes in cash 23.80%-11.25M61.14%-6.4M47.02%-53.69M17.13%-11.26M48.06%-11.21M33.55%-14.76M62.56%-16.46M-268.41%-101.35M66.90%-13.59M71.02%-21.59M
End cash Position -39.82%60.63M-37.77%71.88M-40.69%78.27M-40.69%78.27M-38.49%89.54M-39.72%100.75M-39.00%115.51M-43.44%131.97M-43.44%131.97M-46.95%145.56M
Free cash flow 23.23%-11.33M61.02%-6.43M47.20%-53.73M17.13%-11.26M48.28%-11.21M33.55%-14.76M62.75%-16.49M41.61%-101.75M67.43%-13.59M71.28%-21.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.14%